Breast Cancer (Therapy)
Proven Superiority of High Dose Chemotherapy for Metastatic Disease
Published in Women's Health Weekly, November 25th, 1996
Despite early diagnosis and improvements in adjuvant therapy, the mortality rate for breast cancer remains high. Currently, some 30 percent of patients who appear to have clinically localized disease will die of metastatic breast cancer. This figure jumps to 70 percent for those patients who have poor prognostic features at diagnosis (e.g., >10 nodes positive). Once the cancer has metastasized, the disease is essentially incurable with conventional treatment protocols.
In an effort to overcome the limitations of conventional treatments, high dose...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer (Increased Risk)
Low Levels of Estrogen-Like Chemicals in Drinking Water - Breast Cancer (Reconstruction)
Indigent Women with Cancer Offered Reconstruction Infrequently - Breast Cancer (Screening)
African-American Perceptions of Mammography Differ by Age - Breast Cancer (Surgery)
Managed-Care Group Recommends Hospital Stay For Mastectomies - Breast Cancer (Vaccines)
Doctors Test Vaccine on Oregon Woman - Cardiology
Risk of Stroke, Second Heart Attacks Lowered with Drugs - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
